At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Moxifloxacin 0.5% ophthalmic solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Parallel-group Study of Ocular Penetration of Peri-operative Topically Administered Fluoroquinolones With Cataract Surgery
In Brief
A Phase 4 clinical trial evaluating Moxifloxacin 0.5% ophthalmic solution and Besifloxacin 0.6% ophthalmic suspension for Cataract Extraction. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This study is being conducted to evaluate the intraocular penetration of Moxifloxacin 0.5% ophthalmic solution (Vigamox) and Besifloxacin 0.6% ophthalmic suspension (Besivance) after pre-operative topical administration in subjects undergoing cataract surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract Extraction
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 2009
Enrollment StartSep 2009
Primary CompletionOct 2009
Study CompletionNov 2009
TodayJul 2026
First PostedJun 19, 2009
Enrollment StartSep 1, 2009
Primary CompletionOct 1, 2009
Study CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.0 years ago
Interventions
Moxifloxacin 0.5% ophthalmic solutiondrug
Administer moxifloxacin study drug prior to cataract surgery.
Besifloxacin 0.6% ophthalmic suspensiondrug
Administer besifloxacin study drug prior to cataract surgery.